Free Trial

Procter & Gamble (NYSE:PG) Trading Down 0.1%

Shares of The Procter & Gamble Company (NYSE:PG - Get Free Report) dropped 0.1% on Monday . The company traded as low as $166.57 and last traded at $166.65. Approximately 1,197,617 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 6,761,897 shares. The stock had previously closed at $166.85.

Wall Street Analyst Weigh In

PG has been the topic of several recent research reports. Stifel Nicolaus boosted their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a "hold" rating in a research report on Wednesday, January 24th. Barclays lifted their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 23rd. Argus increased their target price on Procter & Gamble from $180.00 to $185.00 and gave the company a "buy" rating in a report on Thursday, April 25th. StockNews.com cut Procter & Gamble from a "buy" rating to a "hold" rating in a report on Thursday, February 29th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Procter & Gamble from $172.00 to $171.00 and set a "buy" rating on the stock in a research note on Monday, April 22nd. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $169.76.


Get Our Latest Research Report on Procter & Gamble

Procter & Gamble Stock Down 0.6 %

The stock has a fifty day moving average of $160.63 and a two-hundred day moving average of $154.84. The stock has a market cap of $391.48 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 3.39 and a beta of 0.43. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the prior year, the company earned $1.37 EPS. The company's revenue was up .6% on a year-over-year basis. As a group, analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.43%. This is a boost from Procter & Gamble's previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble's dividend payout ratio is 65.69%.

Insider Buying and Selling at Procter & Gamble

In related news, insider Susan Street Whaley sold 3,865 shares of the business's stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total transaction of $620,719.00. Following the transaction, the insider now directly owns 11,886 shares of the company's stock, valued at approximately $1,908,891.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Susan Street Whaley sold 3,865 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the transaction, the insider now directly owns 11,886 shares of the company's stock, valued at $1,908,891.60. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO R. Alexandra Keith sold 776 shares of the firm's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares of the company's stock, valued at $768,256.49. The disclosure for this sale can be found here. Insiders have sold 140,112 shares of company stock valued at $22,841,321 over the last three months. 0.17% of the stock is owned by company insiders.

Institutional Trading of Procter & Gamble

A number of hedge funds have recently made changes to their positions in the stock. Advantage Trust Co bought a new stake in Procter & Gamble in the fourth quarter valued at about $28,000. Naples Money Management LLC bought a new stake in shares of Procter & Gamble in the 4th quarter valued at approximately $29,000. Ruedi Wealth Management Inc. raised its position in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company's stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. Wyrmwood Management LLC bought a new position in Procter & Gamble during the fourth quarter worth $29,000. Finally, Transcendent Capital Group LLC acquired a new position in Procter & Gamble in the fourth quarter worth $31,000. Institutional investors and hedge funds own 65.77% of the company's stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Search Headlines: